T1	PrimaryOutcome 9 37	Time to clinical improvement
T2	OutcomeDefinition 91 211	improvement was defined as improvement of at least two points from the baseline status on the six-category ordinal scale
R1	DefinedAs Arg1:T1 Arg2:T2	
T3	OutcomeDefinition 223 516	scale contains the subsequent categories: (1) death (2) hospital admission requiring invasive mechanical ventilation (3) hospital admission, requiring non-invasive positive pressure ventilation (4) hospital admission, requiring oxygen (5) hospital admission, not requiring oxygen (6) discharge
R2	DefinedAs Arg1:T1 Arg2:T3	
T4	SecondaryOutcome 542 569	clinical status of patients
T5	TimeFrame 570 589	at day 7, 14 and 28
R3	MeasuredAt Arg1:T4 Arg2:T5	
T6	SecondaryOutcome 591 625	ICU admission and intubation rates
T7	SecondaryOutcome 627 665	length of hospitalization and ICU stay
T8	SecondaryOutcome 678 687	mortality
T9	TimeFrame 671 677	28-day
R4	MeasuredAt Arg1:T8 Arg2:T9	
T10	OtherOutcome 689 701	Side effects
T11	OtherOutcome 735 749	adverse events
T12	OutcomeDefinition 868 1006	according to the common terminology criteria for adverse events (CTCAE), National Institutes of Health and National Cancer Institute, 2017
R5	DefinedAs Arg1:T11 Arg2:T12	
T13	OtherOutcome 1013 1034	serious complications
T14	OutcomeDefinition 1069 1214	such as acute respiratory distress syndrome (ARDS), nosocomial infections, septic shock, acute kidney injury (AKI) and acute hepatic injury (AHI)
R6	DefinedAs Arg1:T13 Arg2:T14	
